Back

Circulating concentrations and prognostic value of incretin hormones GLP-1 and GIP-1 in patients with heart failure.

13 May 2024 (14:00 - 15:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Alba Maria Garcia Garcia

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

7 More presentations in this session

Presentation thumbnail
Evaluation of patients with worsening chronic heart failure: clinical value of impedance cardiography
Miss I. Daniliauskaite (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Associations of baseline and changes in insulin-like growth factor binding protein-7 (IGFBP7) levels with heart failure: the PREVEND study
Ms S. Abou Kamar (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Evaluation of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) assay in clinical practice: comparison methods
Assistant Professor A. MAZZA (Adria, IT)
Abstract Slides Video
Presentation thumbnail
Elevating prognostic precision in chronic heart failure through serial cardiac biomarkers, intracardiac pressures, and fluid dynamics.
Mrs Y. Allach (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Spot urinary sodium in outpatients with chronic heart failure. A longitudinal analysis.
Doctor M. Lorenzo Hernandez (Valencia, ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers 2

The Event

Event poster

Heart Failure 2024

13 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
The effect of glucagon-like peptide-1 receptor agonists on patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
thumbnail
Congress Presentation
Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources